June 8 (Reuters) - Use of GLP-1 drugs for diabetes or obesity early in the first trimester of pregnancy, before a woman realizes she is pregnant, is not a cause for alarm, a large new data analysis ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

VERMILION PARISH, La. (KLFY) — Vermilion Catholic school in Abbeville banning some student use of social media, artificial intelligence and technology beginning with the 2026-27 school year. Under the ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Section 1. Purpose. The President relies on subordinates in the executive branch to help him faithfully execute the laws and advance the priorities for which he was elected by the American people.

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors ...

New Mexico is one of six states that has begun using artificial intelligence to comply with a major Medicaid overhaul contained in the “One Big Beautiful Bill Act” that President Donald Trump signed ...

An M142 HIMARS operated by the 7th ID/MDC-PAC launches a missile from Palawan, Philippines, during a live-fire exercise, Apr. 27, 2026. (Staff Sgt. Brandon Rickert/U.S. Army) HONOLULU — The U.S. Army ...

Julia Sullivan is a health and fitness writer, editor and content strategist well as a certified personal trainer. Her byline is in many publications from Harper's Bazaar to SELF Magazine to brand ...

The use of GLP-1 medications for weight loss continues to rise. One drawback associated with GLP-1 medications is that weight loss not only includes fat loss, but muscle loss as well. A new study ...

Serious cases of pancreatitis (inflammation of the pancreas) have been reported with GLP-1 use, but its overall occurrence is considered rare. Large-scale research shows GLP-1s, including Ozempic and ...

Almost half of patients who received etavopivat showed a hemoglobin response of 1g/dL or greater at week 24, compared to 7.2% of those on placebo. (Getty stock photo) Novo Nordisk is gearing up to ...